Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Not listed Not applicable Interventional

CAN-Stim Compared to SNS in Treatment of Urinary Urgency Incontinence With Wireless Neuromodulation Technology

ClinicalTrials.gov ID: NCT02577302

Public ClinicalTrials.gov record NCT02577302. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Sep 2, 2026, 7:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multi-center, Prospective, Randomized, Controlled, Non-Inferiority, Clinical Trial of Chronic Afferent Nerve Stimulation (CAN-Stim) of the Tibial Nerve Versus Sacral Nerve Stimulation (SNS) in the Treatment of Urinary Urgency Incontinence Resulting From Refractory Overactive Bladder (OAB)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a prospective, randomized, controlled, multi-center, study in which 150 evaluable subjects will be randomized 1:1 to receive either a Protect CAN-Stim or SNS InterStim® system. Subjects from both groups will immediately start with therapy. The primary endpoint is a ≥ 50% reduction in number of incontinence episodes associated with urgency at the 3-month visit, with additional measurements assessed at 14 days, 1, 6, 9 and 12-months.

Study identification

NCT ID
NCT02577302
Recruitment status
Not listed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Uro Medical Corporation
Industry
Enrollment
200 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 20, 2018
Primary completion
Sep 30, 2025
Completion
Sep 30, 2025
Last update posted
Oct 3, 2023

2018 – 2025

United States locations

U.S. sites
15
U.S. states
9
U.S. cities
15
Facility City State ZIP Site status
Tilda Research Inc Laguna Hills California 92653 Recruiting
Kaiser Permanente Los Angeles California 90027 Recruiting
University of California Irvine Medical Center Orange California 92868 Recruiting
Westview Clinical Research Placentia California 92870 Recruiting
Advanced Urology Institute Daytona Beach Florida 32114 Recruiting
Baptist Health Miami Cancer Institute Miami Florida 33176 Withdrawn
Florida Urology Partners Tampa Florida 33615 Recruiting
William Beaumont Hospital Royal Oak Michigan 48073 Recruiting
St. Louis Pain Consultants St Louis Missouri 63017 Recruiting
Adult & Pediatric Urology, P.C. Omaha Nebraska 10707 Recruiting
Urology - Iris Cantor Men's Health Center New York New York 10065 Recruiting
Stony Brook University Medical Center Stony Brook New York 11794 Recruiting
Integrated Pain Specialists Columbus Ohio 43240 Recruiting
University of Oklahoma health Sciences Center Oklahoma City Oklahoma 73104 Active, not recruiting
UT Southwestern Medical Center Dallas Texas 75390 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02577302, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 3, 2023 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02577302 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →